J.-L. Wémeau

1.1k total citations
31 papers, 513 citations indexed

About

J.-L. Wémeau is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, J.-L. Wémeau has authored 31 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in J.-L. Wémeau's work include Thyroid Disorders and Treatments (12 papers), Neuroendocrine Tumor Research Advances (7 papers) and Pituitary Gland Disorders and Treatments (6 papers). J.-L. Wémeau is often cited by papers focused on Thyroid Disorders and Treatments (12 papers), Neuroendocrine Tumor Research Advances (7 papers) and Pituitary Gland Disorders and Treatments (6 papers). J.-L. Wémeau collaborates with scholars based in France, Belgium and Switzerland. J.-L. Wémeau's co-authors include Albert Beckers, P. Beck‐Peccoz, Krishna Chatterjee, Andrea Lania, P. Carpentier, M Decoulx, Bruno Carnaille, C Proye, J.-L. Lefebvre and Apostolos Goropoulos and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, World Journal of Surgery and European Thyroid Journal.

In The Last Decade

J.-L. Wémeau

28 papers receiving 494 citations

Peers

Countries citing papers authored by J.-L. Wémeau

Since Specialization

Citations

This map shows the geographic impact of J.-L. Wémeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-L. Wémeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-L. Wémeau more than expected).

Fields of papers citing papers by J.-L. Wémeau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-L. Wémeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-L. Wémeau. The network helps show where J.-L. Wémeau may publish in the future.

Co-authorship network of co-authors of J.-L. Wémeau

This figure shows the co-authorship network connecting the top 25 collaborators of J.-L. Wémeau. A scholar is included among the top collaborators of J.-L. Wémeau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-L. Wémeau. J.-L. Wémeau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	2013 European Thyroid Association Guidelines for the Diagnosis and Treatment of Thyrotropin-Secreting Pituitary Tumors 2013 ·European Thyroid Journal ·P. Beck‐Peccoz, Andrea Lania, Albert Beckers, Krishna Chatterjee, J.-L. Wémeau	162
2	Hyperparathyroïdie primaire 2009 ·Journal de Radiologie ·J.-L. Wémeau	2
3	TSH-secreting adenoma improved with cabergoline 2008 ·Annales d Endocrinologie ·(unknown), (unknown), Christine Cortet‐Rudelli, Richard Assaker, G. Soto-Ares, Sabine Defoort‐Dhellemmes, S. Blond, J.-L. Wémeau, Marie‐Christine Vantyghem	9
4	11β-hydroxystéroïde déshydrogénases. Avancées récentes 2007 ·Annales d Endocrinologie ·Marie‐Christine Vantyghem, (unknown), F. Defrance, J.-L. Wémeau	10
5	Le récepteur sensible au calcium : physiologie et pathologie 2006 ·Annales d Endocrinologie ·(unknown), (unknown), Marie‐Françoise Odou, Nicole Porchet, J.-L. Wémeau, Marie‐Christine Vantyghem	3
6	Prise en charge de l’hyperparathyroïdie primaire asymptomatique 2006 ·Annales d Endocrinologie ·(unknown), Philippe Chanson, B. Conte‐Devolx, Brigitte Delemer, (unknown), J F Henry, Pascal Houillier, J.L. Kraimps, (unknown), V. Rohmer, Antoine Tabarin, (unknown), G. Vidal-Trécan, J.-L. Wémeau, G. Weryha	21
7	Octreotide (Long-Acting Release Formulation) Treatment in Patients with Graves’ Orbitopathy: Clinical Results of a Four-Month, Randomized, Placebo-Controlled, Double-Blind Study 2005 ·The Journal of Clinical Endocrinology & Metabolism ·J.-L. Wémeau, Philippe Caron, Albert Beckers, V. Rohmer, Jacques Orgiazzi, Françoise Borson‐Chazot, M Nocaudie, Petros Perimenis, Ségolène Bisot-Locard, I. Bourdeix, S. Dejager	57
8	Carcinome à petites cellules de l'ovaire hypercalcémiant révélé par un épisode de pancréatite aiguë : à propos d'un cas 2004 ·Gynécologie Obstétrique & Fertilité ·(unknown), (unknown), Éric Lambaudie, Malik Boukerrou, Annick Chevalier-Place, (unknown), Martin Parent, M.C. Baranzelli, Véronique Cabaret, J.-L. Wémeau, Denis Querleu	10
9	[Physiology and pathophysiology of thyroid hormone receptors: the contributions of murine models]. 2000 ·PubMed ·Virginie Vlaeminck‐Guillem, J.-L. Wémeau	4
10	[Two-center evaluation of eight kits for antithyroid peroxidase autoantibodies determinations]. 2000 ·PubMed ·M. D’Herbomez, R Sapin, F Gasser, Jean-Louis Schlienger, J.-L. Wémeau	1
11	Les syndromes de résistance aux hormones thyroïdiennes : aspects cliniques 1999 ·La Revue de Médecine Interne ·Virginie Vlaeminck‐Guillem, J.-L. Wémeau	3
12	Pseudohypoparathyroïdies : hétérogénéité clinique et moléculaire. 1999 ·médecine/sciences ·Virginie Vlaeminck‐Guillem, J.-L. Wémeau	1
13	[Hyperthyroidism. Etiology, physiopathology, diagnosis, evolution, treatment]. 1998 ·PubMed ·J.-L. Wémeau	1
14	Efficacy of low-dose pravastatin in patients with mild hyperlipidemia associated with type II diabetes mellitus. 1997 ·PubMed ·Michel Krempf, F Berthezène, J.-L. Wémeau, (unknown), (unknown), (unknown), P Passa	5
15	Syndromes de résistance aux hormones thyroïdiennes : bases moléculaires et pathogéniques 1997 ·médecine/sciences ·Virginie Vlaeminck‐Guillem, J.-L. Wémeau	1
16	Dysfonctions thyroïdiennes liées à l'amiodarone. Enquête prospective chez 116 sujets 1993 ·La Revue de Médecine Interne ·J.-L. Wémeau, (unknown), (unknown), (unknown), (unknown), M. D’Herbomez, F. Devemy, M Decoulx	0
17	Use ofm-[¹³¹I]Iodobenzylguanidine in the Treatment of Malignant Pheochromocytoma 1991 ·The Journal of Clinical Endocrinology & Metabolism ·Michel Krempf, J. Lumbroso, R Mornex, A Brendel, J.-L. Wémeau, M J Delisle, Bernard Aubert, P. Carpentier, (unknown), (unknown), M. Guyot, (unknown), X Marchandise, M. Schlumberger, B Charbonnel, (unknown)	62
18	Les thyroïdites du post-partum 1989 ·La Revue de Médecine Interne ·J.-L. Wémeau, Lara Leclerc, (unknown), Didier Dewailly, Roos Leroy, M Decoulx, J Lefèbvre	1
19	Long Term Treatment With the Somatostatin Analog SMS 201–995 in a Patient With a Thyrotropin- and Growth Hormone-Secreting Pituitary Adenoma 1988 ·The Journal of Clinical Endocrinology & Metabolism ·J.-L. Wémeau, Didier Dewailly, R. Leroy, M. D’Herbomez, M Mazzuca, M Decoulx, P Jaquet	33
20	Le dosage du peptide C basal et en réponse au tolbutamide intraveineux dans le dépistage des insulinothérapies abusives (ou abusivement prolongées) 1983 ·La Revue de Médecine Interne ·J.-L. Wémeau, (unknown), R. Beuscart, (unknown), Monique Romon, (unknown), P Fossati	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact